obesity treatment
Eli Lilly’s Retatrutide Shows Remarkable Weight Loss Results in Phase 3 Trial
Eli Lilly’s retatrutide has shown significant weight loss in a Phase 3 trial, potentially revolutionizing obesity treatment.
Next-Gen Weight Loss Drugs Affect Brain Reward Circuit in Mice Study
A recent study reveals that next-gen weight loss drugs affect brain reward circuits in mice, potentially altering emotional well-being and cravings.
Novo’s Weight-Loss Drug Shows Better Lean Mass Preservation Than Lilly’s
Novo’s weight-loss drug has been found to preserve lean body mass better than Lilly’s, marking a significant advancement in obesity treatment options.
Surge in Ozempic Sales Disrupts Mounjaro’s Market Position
The rise of affordable Ozempic is reshaping the obesity medication market, impacting Mounjaro’s sales and competition.
The Rs 12,000 Crore Race for GLP-1 Drugs: Impact on India’s Obesity Crisis
India is witnessing a surge in demand for GLP-1 drugs, potentially transforming obesity treatment while raising regulatory concerns.
Indian Drug Manufacturers Launch Affordable Alternatives to Ozempic and Wegovy
Indian drug manufacturers are introducing affordable alternatives to Ozempic and Wegovy, aiming to enhance access to obesity treatment worldwide.
Torrent Pharma Launches India’s First Oral Semaglutide for Weight Loss
Torrent Pharma has launched India’s first oral semaglutide, alongside an injectable option priced at ₹3,999/month, revolutionizing obesity treatment.
Ozempic Patent Expiration Set to Ignite Weight-Loss Drug Market in India
The Ozempic patent expiration in 2026 will bring generics to India, reshaping the weight-loss drug market amid concerns of misuse.